Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine hCG Injection in ICSI for Recurrent Implantation Failure
NCT03445910Completed
- Sponsor
- Ain Shams University
- Start
- Feb 2018
- Primary completion
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of human chorionic gonadotropin in Recurrent Implantation Failure (RIF) (2 arms), sponsored by Ain Shams University. Primary endpoint: Implantation rate at 6 weeks. Started Feb 2018; status: completed.
02
Drugs
human chorionic gonadotropin
03
Conditions
Recurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT03445910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03445910.